Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUW NASDAQ:DRTSW NASDAQ:HSCSW NASDAQ:NXGLW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.05+34.5%$0.06$0.00▼$0.15N/AN/A32,101 shs1,157 shsDRTSWAlpha Tau Medical$2.06-1.4%$1.61$0.20▼$2.99N/AN/A54,905 shs108,388 shsHSCSWHeart Test Laboratories$0.07+16.2%$0.08$0.03▼$0.20N/AN/A3,141 shs1 shsNXGLWNEXGEL$0.03-15.3%$0.05$0.03▼$0.39N/AN/A10,580 shs387 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%-10.68%-26.31%+19.75%-12.75%DRTSWAlpha Tau Medical+8.80%-15.99%+13.13%+109.58%+765.65%HSCSWHeart Test Laboratories-0.57%+26.27%+15.02%-36.06%+33.78%NXGLWNEXGEL0.00%-0.53%-23.27%-24.80%-84.95%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.05+34.5%$0.06$0.00▼$0.15N/AN/A32,101 shs1,157 shsDRTSWAlpha Tau Medical$2.06-1.4%$1.61$0.20▼$2.99N/AN/A54,905 shs108,388 shsHSCSWHeart Test Laboratories$0.07+16.2%$0.08$0.03▼$0.20N/AN/A3,141 shs1 shsNXGLWNEXGEL$0.03-15.3%$0.05$0.03▼$0.39N/AN/A10,580 shs387 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%-10.68%-26.31%+19.75%-12.75%DRTSWAlpha Tau Medical+8.80%-15.99%+13.13%+109.58%+765.65%HSCSWHeart Test Laboratories-0.57%+26.27%+15.02%-36.06%+33.78%NXGLWNEXGEL0.00%-0.53%-23.27%-24.80%-84.95%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/AHSCSWHeart Test Laboratories 0.00N/AN/AN/ANXGLWNEXGEL 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AHSCSWHeart Test Laboratories$8.67KN/AN/AN/AN/AN/ANXGLWNEXGEL$11.27MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)HSCSWHeart Test LaboratoriesN/AN/AN/AN/AN/AN/AN/AN/A7/22/2026 (Estimated)NXGLWNEXGELN/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AHSCSWHeart Test LaboratoriesN/AN/AN/AN/AN/ANXGLWNEXGELN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/ADRTSWAlpha Tau MedicalN/AHSCSWHeart Test LaboratoriesN/ANXGLWNEXGELN/AInsider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/ADRTSWAlpha Tau MedicalN/AHSCSWHeart Test LaboratoriesN/ANXGLWNEXGELN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionableHSCSWHeart Test Laboratories10N/AN/ANot OptionableNXGLWNEXGEL10N/AN/ANot OptionableNXGLW, DRTSW, ANZUW, and HSCSW HeadlinesRecent News About These CompaniesNEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18thJune 4, 2026 | globenewswire.comNEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume ConcentrationMay 19, 2026 | globenewswire.comNEXGEL Strengthens Board with Sequence LifeScience LeadersMay 12, 2026 | tipranks.comNEXGEL To Report First Quarter 2026 Financial Results on May 15thMay 12, 2026 | globenewswire.comNexGel Acquires Celularity Regenerative Biomaterials in Transformative DealMarch 10, 2026 | tipranks.comNexGel Secures Convertible Note Financing for AcquisitionFebruary 11, 2026 | tipranks.comNexGel Inc Reports Q3 2025 Financial ResultsNovember 12, 2025 | tipranks.comNEXGEL, Inc. Reports Steady Q3 2025 PerformanceNovember 11, 2025 | tipranks.comNexGel Inc Appoints Steven Ciardiello to BoardAugust 5, 2025 | tipranks.comMedia Sentiment Over TimeNXGLW, DRTSW, ANZUW, and HSCSW Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.05 +0.01 (+34.48%) As of 06/11/2026Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Alpha Tau Medical NASDAQ:DRTSW$2.06 -0.03 (-1.39%) Closing price 03:58 PM EasternExtended Trading$2.08 +0.01 (+0.68%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.Heart Test Laboratories NASDAQ:HSCSW$0.07 +0.01 (+16.17%) As of 09:30 AM Eastern This is a fair market value price provided by Massive. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.NEXGEL NASDAQ:NXGLW$0.03 0.00 (-11.63%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more.NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
